Abnormal myofiber morphology and limb dysfunction in claudication

Journal of Surgical Research

Volumn 196, Issue 1, 2015, Pages 172-179

  Koutakis, Panagiotis ^a   Myers, Sara A ^b   Cluff, Kim ^c   Ha, Duy M ^a   Haynatzki, Gleb ^d   McComb, Rodney D ^a   Uchida, Koji ^e   Miserlis, Dimitrios ^a   Papoutsi, Evlampia ^a   Johanning, Jason M ^a,f   Casale, George P ^a   Pipinos, Iraklis I ^a,f  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^c Wichita State University   (United States)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^e NAGOYA UNIVERSITY   (Japan)

^f VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Claudication; Myofiber morphology; Walking distance

Indexed keywords

ADULT; ARTICLE; ASSOCIATION; CLAUDICATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; DENSITY; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; MUSCLE BIOPSY; MUSCLE STRENGTH; MYOPATHY; PERIMETER; PRIORITY JOURNAL; SMOKING; WALKING; AGED; INTERMITTENT CLAUDICATION; LIMB; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

AGED; EXTREMITIES; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; MUSCLE STRENGTH;

EID: 84929274039     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.02.011     Document Type: Article

References (40)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones American Heart Association Statistics C Stroke Statistics Subcommittee Executive summary: heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 188
2. D.J. Weiss, G.P. Casale, and P. Koutakis Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease J Translational Med 11 2013 230
3. L. Norgren, W.R. Hiatt, and J.A. Dormandy Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5
4. E.P. Brass, and W.R. Hiatt Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease Vasc Med 5 2000 55
5. Pipinos II, A.R. Judge, and J.T. Selsby The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction Vasc Endovascular Surg 41 2007 481
6. Pipinos II, A.R. Judge, and J.T. Selsby The myopathy of peripheral arterial occlusive disease: part 2. Oxidative stress, neuropathy, and shift in muscle fiber type Vasc Endovascular Surg 42 2008 101
7. M.M. McDermott, K. Liu, and L. Tian Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study J Am Coll Cardiol 59 2012 1159
8. A.W. Gardner, and L.A. Killewich Lack of functional benefits following infrainguinal bypass in peripheral arterial occlusive disease patients Vasc Med 6 2001 9
9. A.W. Gardner, J.S. Skinner, B.W. Cantwell, and L.K. Smith Prediction of claudication pain from clinical measurements obtained at rest Med Sci Sports Exerc 24 1992 163
10. P. Koutakis, J.M. Johanning, and G.R. Haynatzki Abnormal joint powers before and after the onset of claudication symptoms J Vasc Surg 52 2010 340
11. P. Koutakis, Pipinos II, S.A. Myers, N. Stergiou, T.G. Lynch, and J.M. Johanning Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication J Vasc Surg 51 2010 80
12. M.M. McDermott, M.H. Criqui, and P. Greenland Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance J Vasc Surg 39 2004 523
13. B. Pernow, and S. Zetterquist Metabolic evaluation of the leg blood flow in claudicating patients with arterial obstructions at different levels Scand J Clin Lab Invest 21 1968 277
14. Pipinos II, A.R. Judge, and Z. Zhu Mitochondrial defects and oxidative damage in patients with peripheral arterial disease Free Radic Biol Med 41 2006 262
15. B. Hedberg, K.A. Angquist, K. Henriksson-Larsen, and M. Sjostrom Fibre loss and distribution in skeletal muscle from patients with severe peripheral arterial insufficiency Eur J Vasc Surg 3 1989 315
16. B. Hedberg, K.A. Angquist, and M. Sjostrom Peripheral arterial insufficiency and the fine structure of the gastrocnemius muscle Int Angiol 7 1988 50
17. J. Makitie, and H. Teravainen Histochemical changes in striated muscle in patients with intermittent claudication Arch Pathol Lab Med 101 1977 658
18. P. Koutakis, D.J. Weiss, and D. Miserlis Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective Redox Biol 2 2014 921
19. J.G. Regensteiner, E.E. Wolfel, and E.P. Brass Chronic changes in skeletal muscle histology and function in peripheral arterial disease Circulation 87 1993 413
20. K. Cluff, D. Miserlis, and G.K. Naganathan Morphometric analysis of gastrocnemius muscle biopsies from patients with peripheral arterial disease: objective grading of muscle degeneration Am J Physiol Regul Integr Comp Physiol 305 2013 R291
21. P. Koutakis, D. Miserlis, and S.A. Myers Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function J Histochem Cytochem 63 2015 256
22. R. Celis, Pipinos II, M.M. Scott-Pandorf, S.A. Myers, N. Stergiou, and J.M. Johanning Peripheral arterial disease affects kinematics during walking J Vasc Surg 49 2009 127
23. S.A. Myers, Pipinos II, J.M. Johanning, and N. Stergiou Gait variability of patients with intermittent claudication is similar before and after the onset of claudication pain Clin Biomech 26 2011 729
24. M.M. Scott-Pandorf, N. Stergiou, J.M. Johanning, L. Robinson, T.G. Lynch, and Pipinos II Peripheral arterial disease affects ground reaction forces during walking J Vasc Surg 46 2007 491
25. S.R. Wurdeman, P. Koutakis, S.A. Myers, J.M. Johanning, Pipinos II, and N. Stergiou Patients with peripheral arterial disease exhibit reduced joint powers compared to velocity-matched controls Gait & Posture 36 2012 506
26. T.A. Bauer, E.P. Brass, and W.R. Hiatt Impaired muscle oxygen use at onset of exercise in peripheral arterial disease J Vasc Surg 40 2004 488
27. M.M. McDermott, J.M. Guralnik, and L. Ferrucci Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial disease J Vasc Surg 46 2007 87
28. K.I. Makris, A.A. Nella, and Z. Zhu Mitochondriopathy of peripheral arterial disease Vascular 15 2007 336
29. G. Brevetti, G. Giugliano, L. Brevetti, and W.R. Hiatt Inflammation in peripheral artery disease Circulation 122 2010 1862
30. R. Spirig, J. Tsui, and S. Shaw The emerging role of TLR and innate immunity in cardiovascular disease Cardiol Res Pract 2012 2012 181394
31. R.J. Bloch, and H. Gonzalez-Serratos Lateral force transmission across costameres in skeletal muscle Exerc Sport Sci Rev 31 2003 73
32. J.W. Sanger, J.M. Sanger, and C. Franzini-Armstrong Assembly of the skeletal muscle cell A.G. Engel, C. Franzini-Armstrong, Myology 2004 McGraw-Hill New York, NY, USA 45
33. J.W. Sanger, J. Wang, Y. Fan, J. White, and J.M. Sanger Assembly and dynamics of myofibrils J Biomed Biotechnol 2010 2010 858606
34. M. Fanin, A.C. Nascimbeni, and C. Angelini Muscle atrophy in limb girdle muscular dystrophy 2A: a morphometric and molecular study Neuropathol Appl Neurobiol 39 2013 762
35. T. Hortobagyi, L. Dempsey, and D. Fraser Changes in muscle strength, muscle fibre size and myofibrillar gene expression after immobilization and retraining in humans J Physiol 524 Pt 1 2000 293
36. S. Dodson, V.E. Baracos, and A. Jatoi Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies Annu Rev Med 62 2011 265
37. T.S. Creasy, P.J. McMillan, E.W. Fletcher, J. Collin, and P.J. Morris Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial Eur J Vasc Surg 4 1990 135
38. M. Brotto, and E.L. Abreu Sarcopenia: pharmacology of today and tomorrow J Pharmacol Exp Ther 343 2012 540
39. C. Barillaro, R. Liperoti, A.M. Martone, G. Onder, and F. Landi The new metabolic treatments for sarcopenia Aging Clin Exp Res 25 2013 119
40. W.C. Chumlea, M. Cesari, W.J. Evans International Working Group on Sarcopenia Task Force Members Sarcopenia: designing phase IIB trials J Nutr Health Aging 15 2011 450